Key facts
- This page summarizes Sasha King's Form 4 filing for CareDx, Inc. (CDNA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Aug 2022, 21:51.
Sasha King - 09 Aug 2022 Form 4 Insider Report for CareDx, Inc. (CDNA)
- Reporting relationship
- Chief Marketing Officer
- Issuer ticker
- CDNA
- Reported as of
- 09 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Aug 2022, 21:51:11 UTC
- Prior SEC filing
- 03 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Reginald Seeto, as attorney-in-fact for Sasha King
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Sasha King filed Form 4 for CareDx, Inc. (CDNA) on 11 Aug 2022.
Change
- Previous filing in this sequence was filed on 03 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDNA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +31,298
- Change %
- +66%
- Price
- $0.000000
- Shares after
- 78,420
- Date
- 09 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDNA
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +62,160
- Change %
- Price
- $0.000000
- Shares after
- 62,160
- Date
- 09 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 62,160
- Exercise price
- $23.48
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The reported securities are represented by restricted stock units, 1/3rd of which shall vest on June 16, 2023 and 1/3rd of which shall vest on each anniversary thereafter.
Footnote F2
1/4th of the shares subject to the option shall vest on June 16, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter.